MRK — Merck KGaA — Stock Newsroom

S&P 500 6,841 +0.86%

DJIA 48,348 +0.92%

Nasdaq 25,099 +0.82%

DAX 23,937 -0.11%

Gold $4,196 +0.16%

Oil $95.76 -0.96%

BTC $72,438 +1.50%

VIX 20.48 -15.65%

EUR/USD 1.1785 -0.02%

ETH $2,222 +0.59%

S&P 500 6,841 +0.86%

DJIA 48,348 +0.92%

Nasdaq 25,099 +0.82%

DAX 23,937 -0.11%

Gold $4,196 +0.16%

Oil $95.76 -0.96%

BTC $72,438 +1.50%

VIX 20.48 -15.65%

EUR/USD 1.1785 -0.02%

ETH $2,222 +0.59%

MRK

Merck KGaA

XETRA

Healthcare Drug Manufacturers - Specialty & Generic

$119.37

+2.69 (+2.58%)

Data provided by Interactive Brokers. Prices may be delayed.

About Merck KGaA

CEO: Robert Davis

Website: emdgroup.com

Price Chart

Articles (1)

All Articles about Merck KGaA

Pharma & Healthcare

Can the Merck Terns Acquisition really plug the looming Keytruda revenue gap or is $6.7 billion just a high-risk oncology bet? Maik Kemper Editor in…

Mar 25, 2026

News Feed

Real-time news feed for MRK is coming soon.
Check back for live market news and analyst updates.

Sector	Healthcare
Industry	Drug Manufacturers - Specialty & Generic
HQ	Darmstadt